Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Interventional, Cross-sectional Study to Describe Health-related Quality of Life Among Controlled and Uncontrolled Patients With Nonvalvular Atrial Fibrillation on Anticoagulants. RE-QUOL Study.

NCT03134911 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03134911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03134911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Interventional, Cross-sectional Study to Describe Health-related Quality of Life Among Controlled and Uncontrolled Patients With Nonvalvular Atrial Fibrillation on Anticoagulants. RE-QUOL Study.
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
April 24, 2017
Completion date
January 31, 2018
Enrollment
535 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation